Zepp Health CORP

Form 420-F13G

Insider Trading (Form 4)

NYSE
Zepp Health Corp's Chief Technology Officer, Meihui Fan, acquired 520,000 Class A ordinary shares and was granted multiple option tranches on June 26, 2026.
NYSE
Zepp Health Corp's Chief Financial Officer, Cheng Deng, sold a portion of American Depositary Shares to cover tax obligations following the vesting of restricted share units.

Schedule 13G - Passive Investments

See all →
NYSE
Millennium Management and affiliated entities have filed a Schedule 13G amendment, reporting no beneficial ownership of Zepp Health Corporation's Class A Ordinary Shares.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.8% of Zepp Health Corp's Class A Ordinary Shares/ADRs.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.8% of Zepp Health Corp's Class A Ordinary Shares/ADRs.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has disclosed beneficial ownership of 8.5% of Zepp Health Corp's Class A Common Stock as of June 30, 2026.
NYSE
Morgan Stanley has filed a Schedule 13G reporting a 7.5% beneficial ownership stake in Zepp Health Corp.
NYSE
FIL Limited, along with its affiliates Pandanus Partners, L.P. and Pandanus Associates, Inc., has reported beneficial ownership of 10.0% of Zepp Health Corp's Class A Common Stock as of March 31, 2026.